Makale detayı · 2024 · article
Long Term Growth Hormone Therapy in a Patient with IGF1R Deletion Accompanied by Delayed Puberty and Central Hypothyroidism
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıJournal of Clinical Research in Pediatric Endocrinology
- Katalog eşleşmesi (ISSN)JCRPE Journal of Clinical Research in Pediatric Endocrinology
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
What is already known on this topic: Insulin-like growth factor-1 (IGF-1) is the main driver of growth during prenatal life.Patients with IGF1R defects exhibit variable phenotypic features.The most common symptom is pre-and postnatal growth retardation, followed by microcephaly, developmental delay, facial dysmorphism and extremity anomalies.rhGH has been used in patients with IGF1R defects with variable treatment responses What this study adds: Long-term rhGH with an early onset may have more beneficial effects in terms of induction of growth.Regarding the complex physiological effects of IGF1, patients should be followed for hormone deficiencies such as hypogonadism and hypothyroidism.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
2atıfOpenAlex · cited_by_count (önbellek / veritabanı)